








is­ the­ Ras-superfamily­ protein­ Rab1,­ which­ regulates­ various­
steps­of­vesicle­trafficking­in­eukaryotic­cells.­Rab1­is­manipulated­
by­several­Legionella­effectors,­including­DrrA/SidM,­LidA,­and­
LepB­ (Machner­ and­ Isberg,­ 2006;­Murata­ et­ al.,­ 2006).­DrrA/
SidM­is­a­multifunctional­protein,­containing­guanine­nucleotide­
exchange­activity­and­adenylyltransferase­activity­(Ingmundson­















ing­ successful­ intracellular­ infection­ (Ivanov­ and­Roy,­ 2009).­To­















mophila,­virulence­mechanisms­utilized­by­L. longbeachae and­L. 
bozemanii are­largely­unknown.
Legionella pneumophila­ is­ able­ to­multiply­ inside­ eukaryo-
tic­ cells­ –­ either­ in­ free-living­ unicellular­ organisms­ (amebae­
and­ ciliated­ protozoa)­ or­ in­mammalian­ cells­ (macrophages,­
monocytes,­ epithelial­ cells;­ Jules­ and­ Buchrieser,­ 2007).­After­
uptake­ by­ host­ cells,­ the­ Legionella-containing­ phagosome­ is­
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Legionella causes severe pneumonia in humans. The pathogen produces an array of effectors, 
which interfere with host cell functions. Among them are the glucosyltransferases Lgt1, 
Lgt2 and Lgt3 from L.	pneumophila. Lgt1 and Lgt2 are produced predominately in the post-
exponential phase of bacterial growth, while synthesis of Lgt3 is induced mainly in the lag-phase 
before intracellular replication of bacteria starts. Lgt glucosyltransferases are structurally similar 
to clostridial glucosylating toxins. The enzymes use UDP–glucose as a donor substrate and 
modify eukaryotic elongation factor eEF1A at serine-53. This modification results in inhibition 
of protein synthesis and death of target cells.In addition to Lgts, Legionella genomes disclose 
several genes, coding for effector proteins likely to possess glycosyltransferase activities, 
including SetA (subversion of eukaryotic vesicle trafficking A), which influences vesicular 
trafficking in the yeast model system and displays tropism for late endosomal/lysosomal 
compartments of mammalian cells. This review mainly discusses recent results on the 
structure–function relationship of Lgt glucosyltransferases.



















www.frontiersin.org April 2011 | Volume 2 | Article 76 | 1
Review ARticle
published: 12 April 2011
doi: 10.3389/fmicb.2011.00076
achieve­this,­the­bacterium­produces­several­T4SS­effector­proteins­









filament­ rearrangements­ (Chong­ et­ al.,­ 2009)­ or­ regulates­MAP­
kinase­response­to­bacteria­(Li­et­al.,­2009).­Thus,­all­these­findings­
indicate­an­extremely­complex­Legionella-host­cell­interaction.










2003).­ The­ enzymatic­ activity­ is­ sugar-specific,­ i.e.,­ only­ UDP–­
glucose,­ but­ not­ UDP–galactose,­ UDP–N-acetyl-galactosamine,­
UDP–N-acetyl-glucosamine,­ UDP–glucuronic­ acid,­ or­ GDP-
mannose­serves­as­donor­substrate­in­the­reaction­(Belyi­et­al.,­2006).




























cross-reactivity­ (Belyi­ et­ al.,­ 2008).The­ enzymes­ are­ grouped­
into­ the­ glucosyltransferase­ family­GT88­ in­ the­ carbohydrate­
modifying­enzymes­database­(http://www.cazy.org/GT88.html;­
Coutinho­et­al.,­2003).
FigurE 1 | (A) Alignment of partial amino acid sequences of Lgt1, SetA, 
Lpg1961 from L.	pneumophila Philadelphia-1 strain with that of proteins from a 
clostridial glucosylating toxin family: Toxins A and B from C.	difficile, α-toxin 
from C.	novyi, and lethal toxin from C.	sordellii. Gene bank accession numbers 
of the corresponding coding sequences are shown in brackets. Essential 
amino acids mentioned in the text are highlighted (DXD-motif, GT-A triad). 
(B) Alignment of partial amino acid sequences of Lgt1 from L.	pneumophila 
Philadelphia-1 with that of putative glycosyltransferases found in translated 
genomes of L.	drancourtii LLAP12 and L.	longbeachae D-4968. Identification 
codes for Lgt1 and putative glycosyltransferases in strain LLAP12 of L.	
drancourtii and strain D-4968 of L.	longbeachae (two products in each strain) 
are Lpg1368, LDG0102/LDG0103, and LLB0067/LLB3681 respectively. 
Proteins LLO1578 and LLO1721 found in translated sequenced genome of L.	
longbeachae NSW150 were 100% identical to LLB0067 and LLB3681 from L.	
longbeachae D-4968 respectively and are not shown on the figure for 
simplicity reason. Identical amino acid residues are denoted by asterisks, 
highly conserved residues by double dots, and modestly conserved residues 
by dots. The secondary structural elements were deduced from the structure 
of Lgt1 (pdb 3JSZ). The alignment was prepared using ESPript 2.2 (http://
espript.ibcp.fr).
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targeting of eef1a by LegioneLLa 
glucosyltransferases
Legionella­ glucosyltransferase­ 1,­ Lgt2,­ and­ Lgt3­ glucosylate­




















results­are­obtained­ in­ in vivo­ experiments­using­ the­protozoan­
Table 2 | Amino acid sequence identity of proteins of the Lgt-family of L. pneumophila (Philadelphia-1, Corby, Lens, Paris, 2300/99 Alcoy, and 130b). 
Proteins belonging to Lgt1, Lgt2, or Lgt3 groups were cross-aligned pair-wise to determine the degree of identical amino acid residues. The homology is 
shown as a percentage of identical amino acid residues. Lgt1-group glucosyltransferases are marked by green, Lgt2 – by blue, and Lgt3 – by yellow color.
Philadelphia-1  Corby  Lens  Paris  2300/99 Alcoy  130b  
 
lpg2862   lpg1488   L pc0784  L pc0903  L pl1319  L pl1540  L pp1322  L pp1444  L pa02017  L pa02168  L pw13751  L pw15081 
Lpg1368   19.8%  17.0%  98.1%  18.5%  88.6%  17.4%  97.9%  17.0%  98.5%  16.8%  90.1%  16.7%  
lpg2862   26.1%  19.5%  29.7%  22.2%  27.5%  20.6%  26.5%  19.6%  27.0%  22.5%  27.0%  
lpg1488   16.5%  86.2%  15.7%  89.4%  16.1%  94.5%  16.6%  95.3%  16.2%  93.9%  
L pc0784  18.2%  87.8%  16.9%  97.5%  16.2%  99.6%  16.6%  89.3%  16.1%  
L pc0903  17.7%  81.0%  18.3%  84.4%  18.4%  88.5%  18.1%  85.6%  
L pl1319  17.1%  88.6%  15.8%  88.2%  16.1%  96.2%  15.8%  
L pl1540  17.2%  88.2%  17.0%  92.2%  17.3%  94.1%  
L pp1322  16.6%  97.9%  16.7%  90.3%  16.7%  
L pp1444  16.3%  93.3%  16.1%  92.2%  
L pa02017  17.0%  89.7%  16.3%  
L pa02168  16.5%  96.6%  
L pw13751  16.8%  
Table 1 | Comparison of glucosyltransferases Lgt from L. pneumophila with large clostridial toxins.
Property L. pneumophila Lgts Large clostridial toxins
Molecular mass 60–100 kD 250–310 kD
Target substrate Large G-proteins (eEF1A, Hbs1) Small G-proteins (Rho/Ras proteins)
Co-substrates UDP–glucose UDP–glucose, UDP–N-acetyl-glucosamine
CAZY classification GT-A family, GT88 GT-A family, GT44
Target amino acid in substrate Serine Threonine
Stereochemical type of glycosylation Retaining Retaining
Substrate recognition requirements Low High
Intracellular translocation mode Type IV secretion system Receptor-mediated endocytosis
Cellular effect Inhibition of protein synthesis Destruction of the actin cytoskeleton, inhibition of Rho/Ras signaling
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get­ for­ Lgt1.­Hbs1­ shares­ significant­ sequence­ similarities­ with­
eEF1A­(19%­identity)­and­releasing­ factor­eRF3­(24%­identity)­
all­over­the­protein.­Moreover,­yeast­Hbs1­and­human­Hbs1-like­
proteins­ contain­ the­ decapeptides­ 210-GKSSFKFAWI-219­ and­
311-GKASFAYAWV-320,­respectively,­which­are­modified­by­Lgts.­
In vitro,­all­Lgt-family­members­are­capable­of­glucosylating­Hbs1.­










































Serine-53­ of­ eEF1A­ (Figure  2,­ shown­ in­ yellow),­ which­ is­
modified­by­Lgt,­is­located­in­the­G-domain­near­the­switch-1­
region­of­the­GTPase­(Belyi­et­al.,­2006,­2008).­For­the­prokaryotic­
analog­EF-Tu,­ it­ is­known­that­ the­switch-1­region­undergoes­










analysis­ revealed­ that­ considerable­ portions­ of­ the­ elonga-
tion­ factor­ are­ dispensable­ for­ substrate­ recognition.­ Neither­
domains­2­nor­3­of­eEF1A­are­necessary­for­glucosylation.­Even­






surprising­ is­ the­finding­ that­modification­of­ the­decapeptide­
by­Lgt1­is­more­efficient­than­the­glucosylation­of­the­isolated­




FigurE 2 | Structural view of yeast elongation factor eEF1A (adapted 
from pdb 1iJF). Elongation factor eEF1A consists of three main structural 
parts: domain 1 (G-domain), domain 2, and domain 3 (indicated by numbers). 
The decapeptide (GKGSFKYAWV), which is a sufficient substrate for 
glucosylation by Lgt, is shown in red. Serine-53, which is modified by 
glucosyltransferases Lgt, is shown in yellow. The complexed fragment of 
eEF1Bα molecule, which is present in the original structure, is omitted.
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the­same­shift­ is­ recognized­ in­ the­structure­of­C. difficile­ toxin­
B.­ Structural­ analysis­ of­ carbohydrate­metabolizing­ enzymes­ as­
glycosidases­reveal­a­similar­movement­of­the­anomeric­atom­of­














































exhibits­ the­ product state with­ the­ donor­ substrate­ hydrolyzed­
(LppGT·UDP·glucose·Mn2+,­pdb­2WZF).




















(domain­ I)­of­ toxin­B­and­Lgts­ are­ topologically­unrelated­and­
the­function­as­a­subcellular­sorting­signal,­as­found­in­CGTs,­is­
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Thereby­ rearrangement­of­a­ structurally­ conserved­ tryptophan­














In­general­ it­ is­assumed­that­ the­reaction­catalyzed­by­GTs­fol-
lows­a­ sequential­ordered­mechanism.­Here,­ the­metal­ ion­and­
sugar­nucleotide­bind­first­followed­by­the­acceptor­(Qasba­et­al.,­







binding­ to­ the­ donor­ substrate­ (Figure  3A;­Hurtado-Guerrero­
et­ al.,­ 2010).­ This­ conformational­ change­ is­ a­ general­ feature­
FigurE 3 | Cartoon presentation of Lgt1 crystal structure in complex 
with uDP–glucose and Mg2+ (pdb code 3JSZ). (A) The N-terminal domain 
is depicted in blue, the central domain in gray and the protrusion domain 
in brown. The central beta sheet is shaded in light blue. UDP–glucose is 
shown in sticks and Mg2+ as a red sphere. The flexible loop region is 
highlighted in dark red. Aspartic acid residues of the DXD-motif, Trp-520 of 
the flexible loop, Trp-139 stacking the base are shown in sticks. (B) Magnified 
view on the catalytic site of Lgt1 as in (A) with intact UDP–glucose (white) 
and glucose shifted about 1.6 Å after cleavage (dark blue; deduced from 
pdb 2WZF). Important amino acids are shown as sticks. Trp-139 is stacking 
the uracil ring of the donor, Asp-230, Arg-233, and Asp-246 are orientating 
the distal part of glucose as a triade. Asp-248 of the DXD-motif is 
coordinating the divalent ion (red) in conjunction with three additional 
water molecules. Trp-520 of the flexible loop is marked in red. (C) Schematic 
representation of the catalytic site as in (B) with important amino acids marked 
and highlighted.
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flips­into­the­catalytic­pocket.­In­this­state­the­catalytic­­competent­
­conformation­ and­ the­ substrate-binding­ site­ is­ arranged.­ The­
Mn2+­ and/or­ the­ pyrophosphoryl­ group­ abstract­ the­ proton­ of­























































































































ible­ loop­ rearranges­ to­ the­ closed­ conformation­where­Trp-520­
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biology­of­Legionella is­not­known.­One­ speculation­ is­ that­ the­
action­of­Lgt­strongly­decreases­general­metabolism­and­thereby­
antibacterial­ activity­ and,­ thus,­ makes­ host­ cells­ “defenseless”­
against­proliferation­of­invading­bacteria.­On­the­other­hand,­at­
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